11715
Sodium barbiturate
≥97.0% (T)
Synonyme(s) :
Barbituric acid sodium salt
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule empirique (notation de Hill) :
C4H3N2NaO3
Numéro CAS:
Poids moléculaire :
150.07
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
224-507-3
Beilstein/REAXYS Number:
3748030
MDL number:
Assay:
≥97.0% (T)
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderQuality Level
assay
≥97.0% (T)
solubility
hot water: soluble 0.2 g/10 mL, clear, colorless
SMILES string
[Na+].[O-]C1=NC(=O)NC(=O)C1
InChI
1S/C4H4N2O3.Na/c7-2-1-3(8)6-4(9)5-2;/h1H2,(H2,5,6,7,8,9);/q;+1/p-1
InChI key
MHQHHBYRYFICDV-UHFFFAOYSA-M
General description
Sodium barbiturate is a white to light beige powder. It accelerates the propagation of metastatic prostate adenocarcinomas in rats and in tissue culture.
Application
Sodium barbiturate has been used for quantification of thrombin in plasma. It has been used in the estimation of trypsin in duodenal contents. It was also used as a buffer to characterise the functions of two long-chain fatty acid CoA ligase genes (facl) in crude oil-degrading Geobacillus thermodenitrificans NG80-2.
Other Notes
Sales restrictions may apply
Classe de stockage
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Simple method for estimating trypsin.
H S Wiggins
Gut, 8(4), 415-416 (1967-08-01)
M Pollard et al.
Oncology, 34(3), 129-132 (1977-01-01)
Metastatic prostate adenocarcinomas, derived from aging germfree Wistar rats, have been propagated in rats and in tissue culture. A protocol has been developed and demonstrated for assay of treatments which retard or which accelerate the rate and extent of tumor
F A Ofosu et al.
Blood, 64(3), 742-747 (1984-09-01)
Heparan with a low affinity for antithrombin III has previously been demonstrated to inhibit thrombin generation in both normal plasma and plasma depleted of antithrombin III. In addition, standard heparin and heparin with a low affinity for antithrombin III have